Johannes Gutenberg-Universität Mainz
- 6131/39-0
Kalamakis, Georgios; Bruene, Daniel; Ravichandran, Srikanth et al.
Quiescence Modulates Stem Cell Maintenance and Regenerative Capacity in the Aging BrainCELL. Bd. 176. H. 6. 2019 S. 1407-+
Cortes, Jorge E.; Khaled, Samer; Martinelli, Giovanni et al.
Quizartinib versus salvage chemotherapy in relapsed or refractory FLT3-ITD acute myeloid leukaemia (QuANTUM-R): a multicentre, randomised, controlled, open-label, phase 3 trialLANCET ONCOLOGY. Bd. 20. H. 7. 2019 S. 984-997
Gomarteli, Kaga; Fleckenstein, Jens; Kirschner, Stefanie et al.
Radiation-induced malignancies after intensity-modulated versus conventional mediastinal radiotherapy in a small animal modelSCIENTIFIC REPORTS. Bd. 9. 2019
Tanyildizi, Yasemin; Keweloh, Stefanie; Neu, Marie A. et al.
Radiation-induced vascular changes in the intracranial irradiation field in medulloblastoma survivors: An MRI studyRADIOTHERAPY AND ONCOLOGY. Bd. 136. 2019 S. 50-55
Keweloh, Stefanie
Radiogene zerebrovaskuläre Veränderungen bei MedulloblastompatientenMainz: Univ. 2019 126 S.
Klasen, Benedikt; Stergiou, Natascha; Moon, Euy Sung et al.
Radiolabeling and in vitro evaluation of a TA-MUC1 specific monoclonal antibody and its corresponding single chain fragment with zirconium-89, scandium-44, and lutetium-177: Promising tools for diagnosis and therapy of breast cancerJOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS. Bd. 62. 2019 S. S517-S518
Smith, Clayton P.; Czarniecki, Marcin; Mehralivand, Sherif et al.
Radiomics and radiogenomics of prostate cancerABDOMINAL RADIOLOGY. Bd. 44. H. 6. 2019 S. 2021-2029
Labenz, Christian; Toenges, Gerrit; Huber, Yvonne et al.
Raised serum Interleukin-6 identifies patients with liver cirrhosis at high risk for overt hepatic encephalopathyALIMENTARY PHARMACOLOGY & THERAPEUTICS. 2019
Finn, Richard S.; Kudo, Masatoshi; Kang, Yoon-Koo et al.
Ramucirumab (RAM) as second-line treatment in patients with advanced hepatocellular carcinoma (HCC) and elevated baseline alpha-fetoprotein (AFP): An analysis of AFP kinetics in the phase III REACH-2 study.JOURNAL OF CLINICAL ONCOLOGY. Bd. 37. H. 4. 2019
Llovet, Josep M.; Yen, Chia-Jui; Finn, Richard S. et al.
Ramucirumab (RAM) for sorafenib intolerant patients with hepatocellular carcinoma (HCC) and elevated baseline alpha fetoprotein (AFP): Outcomes from two randomized phase 3 studies (REACH, REACH2).JOURNAL OF CLINICAL ONCOLOGY. Bd. 37. H. 15. 2019